Skip to content

Quality of Life in Ventilator-dependant Neuromuscular Patients

Assessment of Quality of Life and Its Determinants in Ventilator-dependent Patients With Slowly Progressive Neuromuscular Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04652401
Acronym
EqualVENT
Enrollment
119
Registered
2020-12-03
Start date
2020-12-02
Completion date
2021-12-07
Last updated
2022-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Diseases, Noninvasive Ventilation, Quality of Life, Respiration, Artificial, Tracheostomy

Brief summary

This study aims at evaluating the quality of life of patients with slowly progressive neuromuscular disorders who are dependant on mechanical ventilation (daily usage ≥ 16h).

Interventions

None listed

Sponsors

Fondation Garches
CollaboratorOTHER
AFM Téléthon
CollaboratorUNKNOWN
FilNeMus
CollaboratorUNKNOWN
Centre d'Investigation Clinique et Technologique 805
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with slowly progressive neuromuscular disorder (NMD), non walking * Patients dependant on mechanical ventilation (daily usage ≥ 16h) for at least 1 year before inclusion * Aged ≥ 18 yo * Consent for participation * Affiliated to a social security regime

Exclusion criteria

* Patients with medically non-stable NMD: fever, acute respiratory infection, organ decompensation * Patients with significant cognitive impairment (inability to read and/or incomprehension of questions) * Patients with fast-evolving neuromuscular disease * Patients declining to participate in the study * Patients under guardianship and/or trusteeship * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Score of the Severe Respiratory Insufficiency questionnaire (SRI)1 DayHigher score represents better quality of life
Score of the Quality of Life Measure for people with slowly progressive and genetic neuromuscular disease questionnaire (QoL-gNMD)1 DayHigher score represents better quality of life

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026